S
Stuart M. Sprague
Researcher at University of Chicago
Publications - 193
Citations - 9501
Stuart M. Sprague is an academic researcher from University of Chicago. The author has contributed to research in topics: Kidney disease & Secondary hyperparathyroidism. The author has an hindex of 47, co-authored 184 publications receiving 8636 citations. Previous affiliations of Stuart M. Sprague include NorthShore University HealthSystem & Rush University Medical Center.
Papers
More filters
Journal ArticleDOI
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Sharon M. Moe,Tilman B. Drüeke,John Cunningham,Wayne K. Goodman,Kevin J. Martin,Klaus Olgaard,Susan M. Ott,Stuart M. Sprague,Norbert Lameire,Garabed Eknoyan +9 more
TL;DR: It is recommended that the term renal osteodystrophy be used exclusively to define alterations in bone morphology associated with CKD, and the term CKD-Mineral and Bone Disorder (CKD-MBD) be used to describe a broader clinical syndrome that develops as a systemic disorder of mineral and bone metabolism due to CKD.
Journal ArticleDOI
Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture
Kyumin Whang,Kevin E. Healy,D. R. Elenz,Ellis K. Nam,D.C. Tsai,Carson H. Thomas,Gordon W. Nuber,F.H. Glorieux,R. Travers,Stuart M. Sprague +9 more
TL;DR: A change in the current paradigm regarding the microarchitecture of scaffolds for in vivo bone regeneration to include mechanisms based on hematoma stabilization is proposed.
Journal ArticleDOI
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.
Stuart M. Sprague,Stuart M. Sprague,Francisco Llach,Francisco Llach,Michael Amdahl,Michael Amdahl,Carol Taccetta,Carol Taccetta,Daniel Batlle,Daniel Batlle +9 more
TL;DR: Paricalcitol treatment reduced PTH concentrations more rapidly with fewer sustained episodes of hypercalcemia and increased Ca x P product than calcitriol therapy.
Journal ArticleDOI
KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Katrin Uhlig,Jeffrey S. Berns,Bryan Kestenbaum,Raj Kumar,Mary B. Leonard,Kevin J. Martin,Stuart M. Sprague,Stanley Goldfarb +7 more
TL;DR: A US perspective on the 2009 KDIGO guideline, which addresses the evaluation and treatment of abnormalities of CKD-MBD in adults and children with CKD stages 3-5 on long-term dialysis therapy or with a kidney transplant, is provided.
Journal ArticleDOI
Increased Risk of Fracture in Patients Receiving Solid Organ Transplants
Rosalind Ramsey-Goldman,Julie E. Dunn,Dorothy D. Dunlop,Frank P. Stuart,Michael Abecassis,Dixon B. Kaufman,Craig B. Langman,Michael H. Salinger,Stuart M. Sprague +8 more
TL;DR: An increased incidence of fractures is shown and the magnitude of this problem in patients undergoing solid organ transplantation is estimated and the need for a long‐term prospective study of fracture risk in these patients is defined.